A phase I study of oral BMS-275291, a novel nonhydroxamate sheddase-sparing matrix metalloproteinase inhibitor, in patients with advanced or metastatic cancer (Q40522459)
Jump to navigation
Jump to search
scientific article published on March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of oral BMS-275291, a novel nonhydroxamate sheddase-sparing matrix metalloproteinase inhibitor, in patients with advanced or metastatic cancer |
scientific article published on March 2004 |
Statements
1 reference
A phase I study of oral BMS-275291, a novel nonhydroxamate sheddase-sparing matrix metalloproteinase inhibitor, in patients with advanced or metastatic cancer (English)
1 reference
Naiyer A Rizvi
1 reference
Jeffrey S Humphrey
1 reference
Elizabeth A Ness
1 reference
Michael D Johnson
1 reference
Elora Gupta
1 reference
Kathleen Williams
1 reference
Diana J Daly
1 reference
Daryl Sonnichsen
1 reference
Delina Conway
1 reference
John Marshall
1 reference
Herbert Hurwitz
1 reference
1 March 2004
1 reference
1 reference
10
1 reference
6
1 reference
1963-1970
1 reference
Identifiers
1 reference
1 reference